The metabolome differs from other omics studies in that the metabolites measured are the end products of gene and protein regulation, and they can directly characterize the physiological pathways and states of the aging process. Metabolomics has the potential to provide innovative insights into the biological processes and molecular mechanisms involved in aging. For metabolomics studies of aging, CD BioSciences provides related services, including age-related metabolic changes, biomarker discovery, and aging clock development.
Metabolites are the end products of metabolism, the levels of which are correlated with aging and age-related diseases. As technology continues to advance and develop, it has high potential to elucidate the aging process, to elucidate metabolite changes resulting from physiological processes of various intrinsic and extrinsic factors, and to serve as a systematic approach to studying and understanding the aging process.
At CD BioScience, our commonly used technological platforms currently available are nuclear magnetic resonance (NMR) spectroscopy, liquid chromatography-mass spectrometry (LC-MS), and gas chromatography-mass spectrometry (GC-MS).
We provide the latest information and state-of-the-art technology in metabolomics studies in aging research to help our clients understand detailed age-dependent metabolite profiles and focus on specific aging biomarkers. All clients have access to our aging metabolomics technology platform for metabolomics services and studies, including basic assays and project-specific support.
Metabolomic Analysis in Aging Research
CD BioSciences employs state-of-the-art techniques and advanced mass spectrometry platforms to perform metabolomic analysis. By profiling the metabolome, our clients can gain a comprehensive understanding of the metabolic changes that occur during the aging process, including detailed metabolite profiles and metabolome functions.
Metabolome-Based Discovery of Aging-Related Biomarkers
We utilize levels of common metabolites as molecular biomarkers of aging, such as hormones, lipids, glucose, amino acids, and cholesterol in the human body, to understand the physiological changes that occur in individuals as they age. The identification of robust aging-related biomarkers can aid in the early detection of age-related diseases, monitoring the efficacy of interventions, and providing insights into the underlying mechanisms of aging.
Metabolome-Based Age Prediction Services
We provide metabolome-based biological age prediction services by measuring and identifying potentially differential metabolomics molecules. It also can be a powerful tool to predict and characterize common age-related diseases such as cancer, diabetes, Parkinson's disease, etc.
Our Core Advantages
Markets We Serve
Depending on the purpose of your aging metabolome study, we use a one-stop metabolomic technology to meet your research needs. We offer analyses suitable for different kinds of biological samples, such as mice, rats, flies, etc., which are commonly used as models for aging studies.
CD BioSciences has extensive experience in senescence metabolomics, and we welcome your inquiries! If you are interested in our services or have any questions, please feel free to contact us to discuss how we can be involved in your research program.
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
CD BioScience is a research service provider focused on aging research, specializing in providing research on aging mechanisms, preclinical drug discovery and development, and the development of healthcare and skincare products.
Copyright © 2024 CD BioSciences. All rights reserved.